DI BELLA METHOD > DOCUMENTATION INDEX > Patient Area - Documents

 
 
Patient Area - Documents
 
 
Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model. (08/04/2011)
Detail
Palliative surgery versus medical management for bowel obstruction in ovarian cancer (08/04/2011)
Detail
Somatostatin and somatostatin receptors: from basic concepts to clinical applications. (08/04/2011)
Detail
A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. (08/04/2011)
Detail
Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5? (08/04/2011)
Detail
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study. (08/04/2011)
Detail
Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. (08/04/2011)
Detail
VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway. (08/04/2011)
Detail
Cancer: antitumor effects of octreotide LAR, a somatostatin analog. (08/04/2011)
Detail
Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue (08/04/2011)
Detail
Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study. (08/04/2011)
Detail
hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells. (08/04/2011)
Detail
Octreotide treatment of patients with hepatocellular carcinoma--a retrospective single centre controlled study. (08/04/2011)
Detail
Octreotide LAR: safety and tolerability issues. (08/04/2011)
Detail
[A case of successful treatment using octreotide acetate for occlusive ileus in terminal stage cancer]. (08/04/2011)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
 
 

Stampa